Patients with inflammatory bowel disease (IBD) without adequate access to urgent medical care for exacerbation of symptoms tend to obtain care from emergency departments (ED), which is associated with an increased use of opiates, steroids, and poor patient satisfaction. We previously described the development of an urgent access toolkit using a Breakthrough Series (BTS) Collaborative as part of IBD Qorus. The aim of this study was to demonstrate the sustainability and clinical impact of implementation of the urgent access toolkit after 1 year.